Your browser doesn't support javascript.
loading
INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial.
Patt, Yehuda Z; Murad, Waheed; Fekrazad, Mohammed H; Baron, Ari D; Bansal, Pranshu; Boumber, Yanis; Steinberg, Kim; Lee, Sang-Joon; Bedrick, Ed; Du, Ruofei; Lee, Fa Chyi.
Afiliação
  • Patt YZ; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
  • Murad W; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
  • Fekrazad MH; University of California Riverside and Kaiser Permanente Riverside, Moreno valley, California.
  • Baron AD; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
  • Bansal P; City of Hope National Medical Center, Durate, California.
  • Boumber Y; Pacific Hematology Oncology Associates, San Francisco, California.
  • Steinberg K; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
  • Lee SJ; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
  • Bedrick E; Fox chase cancer center, Philadelphia, Pennsylvania.
  • Du R; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
  • Lee FC; Division of hematology/oncology, Department of medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
Cancer Med ; 6(9): 2042-2051, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28801995
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias dos Ductos Biliares / Carcinoma Hepatocelular / Desoxicitidina / Cloridrato de Erlotinib / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias dos Ductos Biliares / Carcinoma Hepatocelular / Desoxicitidina / Cloridrato de Erlotinib / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2017 Tipo de documento: Article